ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,109Medicare Part D Prescriptions Filled, Including Refills

Rank: 179 out of 1000

$788K Total Retail Price of All Prescriptions

Rank: 109 out of 1000

298 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 298 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

37% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 8,970 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 799 436 S3 1 1
SIMVASTATIN 444 333 2 3
LEVOTHYROXINE SODIUM 343 253 3 4
AMLODIPINE BESYLATE 316 170 4 6
METFORMIN HCL 312 165 5 8
WARFARIN SODIUM 297 248 6 22
FUROSEMIDE 293 209 7 7
OMEPRAZOLE 273 138 8 2
CARVEDILOL 221 130 9 15
SINGULAIR 199 123 10 84
ZOLPIDEM TARTRATE 186 104 11 16
GABAPENTIN 180 116 12 11
PANTOPRAZOLE SODIUM 173 110 13 28
LYRICA 167 81 14 47
POTASSIUM CHLORIDE 162 131 15 10
NAMENDA 162 141 15 43
ATORVASTATIN CALCIUM 156 108 17 18
LOSARTAN-HYDROCHLOROTHIAZIDE 155 92 18 38
RAMIPRIL 137 89 19 77
DIGOXIN 136 121 20 52
LOSARTAN POTASSIUM 132 120 21 25
CIPROFLOXACIN HCL 131 79 22 46
LOVAZA 130 98 23 148
METOPROLOL TARTRATE 128 102 24 19
MONTELUKAST SODIUM 122 80 25 132
CARISOPRODOL 111 48 R 26 72
METOPROLOL SUCCINATE 110 53 27 21
DIOVAN 108 59 28 67
CYMBALTA 107 88 29 53
CLOPIDOGREL 106 82 30 35
LISINOPRIL 105 50 31 5
DONEPEZIL HCL 103 98 32 32
HYDROCHLOROTHIAZIDE 103 52 32 9
NEXIUM 99 64 34 23
METOCLOPRAMIDE HCL 88 44 35 99
ESCITALOPRAM OXALATE 85 51 36 60
RANITIDINE HCL 85 49 36 37
ALLOPURINOL 83 45 38 31
PRAVASTATIN SODIUM 83 64 38 12
CYCLOBENZAPRINE HCL 82 56 R 40 39
CLONIDINE HCL 81 52 41 27
PLAVIX 80 61 42 49
JANUVIA 79 60 43 85
VENLAFAXINE HCL ER 77 65 44 124
MELOXICAM 77 57 44 14
ATENOLOL 76 46 46 24
TRAZODONE HCL 75 60 47 29
SPIRONOLACTONE 71 63 48 78
CITALOPRAM HBR 69 45 49 17
PREDNISONE 69 59 49 42
DEXAMETHASONE 63 49 51 229
PEN NEEDLE 62 28 52 165
CRESTOR 60 23 53 30
SERTRALINE HCL 59 24 54 26
FLUOXETINE HCL 58 42 55 51
CELEBREX 57 38 56 98
QUINAPRIL HCL 55 29 57 117
ISOSORBIDE DINITRATE 54 50 58 224
AMLODIPINE BESYLATE-BENAZEPRIL 54 43 58 59
KLOR-CON M20 54 27 58 66
SYMBICORT 54 29 58 149
TRIAMTERENE-HCTZ 54 49 58 48
RISPERIDONE 53 53 63 87
SPIRIVA 53 51 63 64
TRAMADOL HCL 52 30 65 13
TAMSULOSIN HCL 51 48 66 33
RANEXA 50 48 67 446
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.